# H2BC12

## Overview
H2BC12 is a gene that encodes the H2B clustered histone 12 protein, a member of the histone H2B family, which plays a pivotal role in the structural organization of chromatin in eukaryotic cells. The H2B clustered histone 12 protein is integral to the formation of nucleosomes, the fundamental units of chromatin, by participating in the assembly of the histone octamer around which DNA is wrapped (Luger1997Crystal). This protein is characterized by a histone-fold motif, which facilitates its interaction with DNA and other histone proteins, contributing to the nucleosome's stability and function (Luger1997Crystal). Post-translational modifications of the H2B protein, such as acetylation and phosphorylation, are crucial for regulating chromatin dynamics and gene expression (Placek2002The). H2BC12 has been implicated in various biological processes and diseases, including its role in chromatin remodeling, cancer progression, and immune response modulation, highlighting its potential as a therapeutic target and biomarker in clinical settings (Zhou2022The; Wang2024Unveiling).

## Structure
The H2BC12 gene encodes a histone protein that is part of the histone H2B family, which plays a crucial role in the nucleosome structure of chromosomal fiber in eukaryotes. The primary structure of histone H2B consists of a sequence of amino acids that form specific secondary structures, including alpha helices and loops. The histone-fold motif, a key structural feature, consists of three α-helices connected by loops L1 and L2, which is shared among core histones like H2B (Luger1997Crystal).

In terms of tertiary structure, the H2B protein forms part of the H2A-H2B dimer, which interacts with DNA and the H3-H4 tetramer, contributing to the nucleosome's structural integrity (Luger1997Crystal). The quaternary structure involves the assembly of these dimers into a histone octamer, around which DNA is wrapped to form the nucleosome core particle (Luger1997Crystal).

Post-translational modifications of H2B, such as acetylation and phosphorylation, occur on the N-terminal tails and influence chromatin structure and activity (Placek2002The). These modifications play a role in regulating the stability and structure of the H2A-H2B dimer (Placek2002The).

## Clinical Significance
The H2BC12 gene has been identified as having significant clinical implications in gliomas, particularly WHO grade II and III gliomas. Studies have shown that H2BC12 mRNA expression is significantly higher in glioma tissues compared to normal tissues, with even higher levels in grade III gliomas compared to grade II. This suggests that H2BC12 may function as an oncogene in gliomas (Zhou2022The). High expression of H2BC12 is associated with poor survival outcomes, including shorter overall survival, disease-specific survival, and progression-free intervals in patients with these gliomas (Zhou2022The).

H2BC12 expression is also linked to various clinicopathologic characteristics, such as IDH status, 1p/19q codeletion, and primary therapy outcomes, indicating its potential as a prognostic biomarker (Zhou2022The). The gene's expression correlates with immune infiltration, showing associations with various immune cells, which may influence the tumor microenvironment and immune response in gliomas (Zhou2022The). These findings suggest that H2BC12 could serve as a potential therapeutic target or biomarker for glioma progression and prognosis (Zhou2022The).

## Interactions
H2BC12, a member of the histone H2B family, is involved in various interactions that influence chromatin structure and gene expression. In the context of proliferative diabetic retinopathy (PDR), H2BC12 was identified as a central protein in a protein-protein interaction (PPI) network constructed using high-confidence data. This network analysis, performed with the cytoHubba plugin in Cytoscape, highlighted H2BC12 as one of the key proteins consistently central across multiple algorithms, suggesting its significant role in the molecular complexity of PDR (Wang2024Unveiling).

In triple-negative breast cancer (TNBC), H2BC12 is among the genes downregulated in olaparib-treated MDA-MB-468 cells. This downregulation suggests that H2BC12 may have a role in the cellular response to olaparib, a PARP inhibitor used in cancer treatment. The study utilized a PPI network to identify hub genes, indicating that H2BC12 might interact with other proteins involved in breast cancer pathways (Hekmatshoar2024The).

In glioma, H2BC12 is part of the H2B gene family, which is associated with immune responses and tumor progression. Although specific interactions of H2BC12 are not detailed, the gene is implicated in regulating the tumor microenvironment and may serve as a therapeutic target (Jia2022H2B).


## References


[1. (Hekmatshoar2024The) Yalda Hekmatshoar. The impact of olaparib on metabolic pathways in triple negative breast cancer: a bioinformatics approach. Medical Records, 6(3):555–560, September 2024. URL: http://dx.doi.org/10.37990/medr.1529503, doi:10.37990/medr.1529503. This article has 0 citations.](https://doi.org/10.37990/medr.1529503)

[2. (Zhou2022The) Jie Zhou, Zhaoquan Xing, Yilei Xiao, Mengyou Li, Xin Li, Ding Wang, and Zhaogang Dong. The value of h2bc12 for predicting poor survival outcomes in patients with who grade ii and iii gliomas. Frontiers in Molecular Biosciences, April 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.816939, doi:10.3389/fmolb.2022.816939. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.816939)

[3. (Luger1997Crystal) Karolin Luger, Armin W. Mäder, Robin K. Richmond, David F. Sargent, and Timothy J. Richmond. Crystal structure of the nucleosome core particle at 2.8 å resolution. Nature, 389(6648):251–260, September 1997. URL: http://dx.doi.org/10.1038/38444, doi:10.1038/38444. This article has 7233 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/38444)

[4. (Placek2002The) Brandon J. Placek and Lisa M. Gloss. The n-terminal tails of the h2a−h2b histones affect dimer structure and stability. Biochemistry, 41(50):14960–14968, November 2002. URL: http://dx.doi.org/10.1021/bi026283k, doi:10.1021/bi026283k. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi026283k)

[5. (Wang2024Unveiling) Jun Wang, Hongyan Sun, Lisha Mou, Ying Lu, Zijing Wu, Zuhui Pu, and Ming-ming Yang. Unveiling the molecular complexity of proliferative diabetic retinopathy through scrna-seq, alphafold 2, and machine learning. Frontiers in Endocrinology, May 2024. URL: http://dx.doi.org/10.3389/fendo.2024.1382896, doi:10.3389/fendo.2024.1382896. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2024.1382896)

[6. (Jia2022H2B) Jingnan Jia, Zhaocheng Han, Xueke Wang, Xiancheng Zheng, Shurui Wang, and Yinglin Cui. H2b gene family: a prognostic biomarker and correlates with immune infiltration in glioma. Frontiers in Oncology, October 2022. URL: http://dx.doi.org/10.3389/fonc.2022.966817, doi:10.3389/fonc.2022.966817. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.966817)